General High School, Podgorica, Montenegro, Yugoslavia (Sept 1976 - June 1980) "A" grades in biology, chemistry and physics Faculty of Medicine, University of Belgrade, Yugoslavia. MD – (Oct 1980 - June 1986)
Postgraduate education and advanced training
Clinical Hospital Centre, Montenegro, Internship (1986 – 1987) State examination in General Medical Practice - November 1987 Clinical Hospital Centre, Montenegro, Casualty ward (1987 – 1990) Medical School, University of Zagreb, Postgraduate Teaching Course in Clinical Immunology and Allergy (1989 - 1991) Westminster Hospital, London, Oncology and Radiotherapy Department, Visiting Fellow (British Scholarship Trust for Yugoslavs) (Oct 1991 - June 1992) Medical School, University of Belgrade (April 1991 - 1995) - Specialist in Internal Medicine (grade: excellent) Lister Postgraduate Institute, Edinburgh, UK. Intensive Course in Clinical Oncology (April 1997) Salzburg, Austria, Cornely Seminar MSKCC, Seminars in Oncology (29th July - 3 Aug 1997) National Oncology Institute, University of Belgrade, Teaching Course in Clinical Oncology (May 1997 - June 1997) The Royal Marsden Hospital, Sutton, Surrey, Visiting Fellow at GI & Lymphoma Unit (Oct 1998 - Nov 1998) ESO Course on Evidence Based Management of Breast Cancer, Sarajevo, 4-6. Oct 2001. Certificate in Clinical Research 2003/2004, School of Medicine, University of Leeds, UK – Attended modules 1 and 2. Breast cancer symposium, NCI, Washington, USA, 2005 – CME credit award
Employment record from 1987
Casualty, CC of Montenegro, Podgorica, from 1987 – 1991. Medical Scool for nurses , Podgorica ,Lecturing , subject Internal Medicine ,from 1988 -1989 Clinic of Internal Medicine, CC of Montenegro, Podgorica, from 1991 – 1995. Oncology Department, CC of Montenegro, Podgorica, Specialist in Internal Medicine, May 1995 – June 1999. - Hospital for Lung diseases, Oncology Dpt. August 1999. - November 1999. - NGO World Vision as MD.
I was responsible for running the Thyroid Clinic. This involved diagnosis, treatment and follow up of patients with thyroid cancers, euthyroid goiter, hyper and hypothyroidism.
Part time work in Casualty department till September 1997, than continue only with the post as Medical Oncology Specialist Senior Registrar running out - patient Chemotherapy clinic as well as patients on word.
Member and one of the initiators of a Breast cancer joint clinic in Clinical Centre of Montenegro. Also initiated organized diagnostic approach, staging, follow up, standard chemotherapy regimens (like CMF, FAC, CAF, Cisplatinum –5FU etc, Tamoxifen, Anastrazol, Letrozole, Paclitaxel, Docetaxel, Capecitabine, Gemcitabine, Navelbin – all of which when available, facing difficulties with shortage of available therapy and therapy discontinuation) with multidisciplinary treatment approach. Working on Breast Cancer Registry (breast cancer incidence was 40 pts on 100 000 women of Montenegro) and made liaison with Lyon IACR which I proceeded to NIH of Montenegro for further development. GI Joint clinic – treatment of metastatic GI tumors. Gynecology Joint Clinic – most of the treated patients suffered ovarian cancer. Urology Clinic – Most of the patients were referred in locally advanced and metastatic stage. I proposed organ preservation treatment approach for bladder cancer. Lung cancer joint clinic – treated locally advanced and extrathoracic stage of the disease. Head and neck joint clinic – Chemotherapy of locally advanced disease.
Publications in Journals and abstract in Oncology to various European Cancer conferences. (List of publications included) Translated book Chemotherapy of Cancer (Steven Carter, Marie Bakowski, Kurt Hellmann) into Serbo Croat Language. Translated booklet Breast cancer, Myths and facts, What you need to know (S. Eva Singletary, MD and Alice F. Judkins RN, MS; MD Anderson, Houston, Texas). World Vision NGO, 1999, 3 months, contract post of Medical mobile Team Leader. Much of the work were organisational type with registering refugees and doing deliveries of food and other goods, polio vaccination, and referral to medical treatment.
Membership of societies
European Society for Therapeutic Radiology and Oncology (ESTRO), since 2000 American Society of Clinical Oncology (ASCO), since 2002 The Multinational association of Supportive Care in Cancer (MASCC), since 2004
LECTURING: 1.Therapy of bladder cancer, Sept. 1997, Science and Education Unit CC of Montenegro 2.Presentation of the translated book “Chemotherapy of Cancer” and Introduction to Clinical Trials, Oct. 1998, Science and Education Unit CC of Montenegro 3.Translational Research ie from Lab to Oncology in Practice, August 2000, Organized by Pharmacies sans Frontieres, Hotel Crna Gora, Podgorica, Montenegro
RESEARCH ACTIVITIES - Proposed to Department for Science and Education: Neoadjuvant Chemotherapy in locally advanced breast cancer patients (since 1996, CHC of Montenegro, Podgorica, Montenegro) Quality Assurance in External Radiotherapy (since 1997, CHC of Montenegro, Podgorica, Montenegro) Adjuvant chemotherapy in High Risk Stage I premenopausal breast cancer patients (since 1998, CHC of Montenegro, Podgorica, Montenegro) Combined Chemo/Radiotherapy Treatment for bladder preservation in patients with bladder cancer stage T3 and T4 (since 1998, CHC of Montenegro, Podgorica, Montenegro)
PROJECTS: 1.QUALITY ASSURANCE OF INTERDISCIPLINARY TREATMENT APPROACH OF BREAST CANCER PATIENTS IN MONTENEGRO 2.PHASE III MULTICENTER, RANDOMISED STUDY OF INTERMITTENT ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL, OPERABLE, HIGH RISK BREAST CANCER PATIENTS 3.MULTICENTER RANDOMISED STUDY OF PRIMARY CHEMOTHERAPY IN PREMENOPAUSAL EARLY STAGE BREAST CANCER PATIENTS
I have experience of medical project management, team work and team leadership. I have good organisation skills, a capacity for independent research and an ability to synthesise research findings. Good command of English and a basic comprehension of Italian Good knowledge of standrad software application Domestic and International driving licence (categ
LIST OF PUBLICATIONS
I/ Domestic congresses and conferences (oral or poster presentation):
1.D. Scepanovic, N. Crnogorac, M. Pavlicic, Nada Bajic, J. Lakicevic, D. Lakic. Rates of distant metastases in premenopausal women with breast cancer (With or without radiotherapy?). XXXIII Annual Meeting of Oncology 1996, Belgrade 2.D. Scepanovic, Nada Bajic. The role of postoperative radiotherapy on disease control in breast cancer patients. Arch Oncol 2000; 8 (Suppl 1): 16 3.Nada Bajic, D. Scepanovic. Chemotherapy of liver metastases in breast cancer patients – is there a place for nihilism? Arch Oncol 2000; 8 (Suppl 1): 18
II/ Full articles (domestic journals):
1.D. Scepanovic, Nada Bajic, R. Kadic, V. Popovic. Multiple endocrine neoplasia Type IIa – Case report. Srp Arh Celok Lek 1994, 7 – 8: 234 – 236 2.Nada Bajic, D. Scepanovic. Optimization of interdisciplinary treatment approach of breast cancer patients in Montenegro. Bilten - Chamber of Medicine of Montenegro 2002; No 2: 36 - 37 3.Nada Bajic, D. Scepanovic. Clinical Trials – From anecdotes to evidence based medicine Review article. Archive of Oncology 2003, 11(1): 273-277 4.D. Scepanovic, Nada Bajic, N. Crnogorac, M. Pavlicic. Rates of distant metastases in premenopausal women with breast cancer (with or without Radiotherapy?). Medicinski zapisi 2003, 57; 38 – 42 5.D. Scepanovic, Nada Bajic , J. Babic. Postmastectomy Radiotherapy and locoregional recurrence rate in high risk breast cancer patients. Archive of Oncology 2004; 12 (1):39 – 43 6.D. Scepanovic, Nada Bajic, J. Babic. Activity of combined gemcitabine therapy on treatment of planocellular carcinoma: A pilot study. Arch Oncol 2004; 12 (2): 109 - 11
III/ Only abstracts (international):
1.D. Scepanovic, Nada Bajic, M. Pavlicic, N. Crnogorac, J. Lakicevic, D. Savjak, D. Lakic. Contralateral breast cancer and distant metastases. ECCO 9 1997, Hamburg 2.Nada Bajic, D. Scepanovic. Whole brain doses and overall survival in patients with brain metastases, 38th ASCO Annual Meeting 2002, May 2002, Orlando, Florida 3.Nada Bajic, D. Scepanovic. Adjuvant therapy as a prognostic factor for early stage breast cancer, 4th Milan Breast Cancer Conference, June 2002, Milan, Italy 4.Nada Bajic, D. Scepanovic. The analyses of disease free survival and overall survival in premenopausal and postmenopausal axillary node negative breast cancer patients, 42nd ASCO Annual Meeting, Atlanta, Georgia, USA, June 2006 5.Danijela Scepanovic, N. Bajic. The influence of rest primary brain tumours on disease free and overall survival, 42nd ASCO Annual Meeting, Atlanta, Georgia, USA, June 2006
IV/ International congresses and conferences (oral or poster presentation):
1.Nada Bajic, D. Scepanovic. Mastectomy in addition to chemotherapy improves relapse free survival in women with locally advanced breast cancer. 1998, 1st European Breast Cancer Conference, Florence 2.D. Scepanovic, P. Aligrudic, Nada Bajic, N. Bjelica. Comparison of manual planning algorithm with two and three dimensional radiotherapy treatment plans for head and neck tumours. ESTRO 1998, Edinburgh 3.D. Scepanovic, Nada Bajic. Activity of Combined Gemcitabine therapy on treatment of planocellular carcinoma – Pilot study, 21st ESTRO, September 2002, Prague 4.D. Scepanovic, Nada Bajic, M. Mijovic, D. Zivkovic, S. Kavaric. Superior sulcus tumors and radiotherapy doses, 16th International Congress on Anti – Cancer Treatment, 1. – 4. February 2005, Paris 5.Nada Bajic, D. Scepanovic. Postmastectomy radiotherapy as adjuvant treatment in breast cancer patients, 7th Milan Breast Cancer Conference, June 2005, Milan, Italy 6.D. Scepanovic, Nada Bajic. Treatment option for head and neck locoregional recurrence, International meeting on innovative approaches in head and neck oncology, EHNS – ESTRO, 22 – 24 February 2007, Barcelona, Spain 7.Nada Bajic, D. Scepanovic. Bisphosphonates in endocrine dependent (breast and prostate) cancer bone metastases cntrol. 20th Anniversary International MASCC/ISSO Symposium, St. Gallen, Switzerland, 27-30 June, 2007, J Supportive Care in Cancer, Vol 15, No 6, June 2007